Skip to main content
. 2019 Jan 25;40:231–239. doi: 10.1016/j.ebiom.2019.01.012

Fig. 7.

Fig. 7

In vitro kinase inhibition by HSN431. The dose-response curves obtained by incubating increasing concentrations of HSN431 with kinases in the (a) PI3K/AKT/mTOR pathway and (b) MAPK pathway. ATP concentration was 100 μM. Refer to Table S1 for concentrations of kinases and corresponding substrates. Each data point represents the mean ± SD of duplicate measurements.